Advanced Genomics is a leading Canada based research, development, and complete health solution provider biotech company. Healthcare reform is a serious and most important issue in the government right now due to increasing cost of drugs and treatments, more side effects, and increasing number of adverse drug reactions. The reason is most of the diseases are not diagnosed properly and are not cured at an early stage. Prescribed drugs are effective only in 40-50% patient population and are not effective in rest of the population, leading only to side effects and adverse drug reactions. All these factors lead to advanced stage of disease that is difficult to treat. We at the Advanced Genomics are very serious in our business to address all these issues. With our two decades of research experience at molecular level, we strongly believe that genomics has the potential to solve these problems. Our advanced technologies, and synergistic genomics and bioinformatics approaches unlock the secrets of genes and raking in the big bucks for the development of better diagnostics, safe and cost effective drugs and personalized treatment procedures. Our mission is to move health care from management model (control or treat segment of disease) to control overall status model.

Some of the diseases are inherited but for most of the diseases, genes, foods and environmental factors play contributory role. Excessive amount of toxins, pollutants, high stress life style that zap the immune system, poor quality food full of pesticides, and pathogens contribute to most of the chronic diseases like cancer, diabetes mellitus, and many other diseases. Advanced Genomics is well positioned to take these three factors into consideration and has developed hybrid business model that blends fee-for service projects, and research and development collaborations in four areas- diverse but integrated domains:

• AdGen Medical –personalized medicine
• AdGen Pharma –pharmacogenomics
• AdGen Enviro ­  –metagenomics and forest genomics
• AdGen Nutri     –nutrigenomics

At Advanced Genomics through our dedication to innovation and scientific excellence, we have developed two pipelines:

Research and Discovery: Advanced genomics is well positioned to rapidly deploy its proven technology to respond to infectious diseases, diabetes, and various types of cancers. Our product development includes early research which encompasses entire spectrum of genomic biomarkers discovery, predictive diagnosis, and analysis of drug response and drug toxicity. We continue to pursue innovative research and new opportunities beyond our targeted disease areas.

Complete Solution: Advanced Genomics offers complete solution right across the value chain, from identification of lead candidate to gene testing. Our expert personnel are specialized in wide range of services starting form wet lab basic research to microarray experimental procedures, data acquisition and analysis, bioinformatics, and database management. We have developed methods to process nanogram sample to distinct disease signatures, and high resolution whole- genome print to improve and speed up clinical applications for health.

Genome based research information from four domains of Advanced Genomics will be gathered together in a database to find out the relationship between these factors to form a disease and also will be used for the improvement of various fields of medicine, pharmaceuticals, environment and nutrition.

Collaborations: We are building deep, long-term collaborations with eminent researchers and medical professionals of similar vision to strengthen the healthcare system.  We are preparing the opportunity of new multi center functional genomics research projects, stimulating technology innovation and industrial collaborations. You can have access to our expertise and resources to turn tissue, blood, and culture samples to distinct disease signatures that enable you to find sustainable and cost-effective solutions for the 21st century health challenges. The information obtained from this genome based research will affect the future development of various fields of medicine, pharmaceuticals, and agriculture.